Harout Semerjian
Vorstandsvorsitzender bei GLYCOMIMETICS, INC.
Vermögen: 42 750 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Harout Semerjian
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
19
| Public Company | Pharmaceuticals: Major | 19 |
| Public Company | Pharmaceuticals: Major | 17 | |
| Subsidiary | Biotechnology | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Harout Semerjian
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chairman Chief Executive Officer Corporate Officer/Principal | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Director/Board Member | |
| MACROGENICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal General Counsel | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Director/Board Member Chairman | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Ipsen Pharmaceuticals, Inc.
 Ipsen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ipsen Pharmaceuticals, Inc. provides pharmaceutical products. The private company is based in Morristown, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Sales & Marketing General Counsel | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Director/Board Member Chairman | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| AXCA HEALPAR | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| BAXALTA INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Washington University in St. Louis | College/University | Doctorate Degree Undergraduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Xinvento BV
 Xinvento BV BiotechnologyHealth Technology Part of Rhythm Pharmaceuticals, Inc., Xinvento BV is a Dutch biotech company that develops therapies for congenital hyperinsulinism. The company is based in Amsterdam, Netherlands. The company was founded in 2021 by Claudine van der Sande, Sarah Hafith-de Boer, Piet Wigerinck. Claudine van der Sande has been the CEO since 2021. Xinvento was acquired by Rhythm Pharmaceuticals Netherlands BV on February 27, 2023 for $222.43 million. | Biotechnology | Founder | |
Atriva Therapeutics GmbH
 Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Biotechnology | Director/Board Member | |
University Hospital Antwerp
 University Hospital Antwerp Hospital/Nursing ManagementHealth Services University Hospital Antwerp provides clinical, patient care, academic training and scientific research services. The company was is headquartered in Belgium. | Hospital/Nursing Management | Director/Board Member | |
miDIAGNOSTICS NV
 miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services miDIAGNOSTICS NV develops a computer chip powered portable medical laboratory. The company is headquartered in Leuven, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
| Tibotec-Virco Comm Va | Corporate Officer/Principal | ||
Drug Discovery & Development Solutions Ltd.
 Drug Discovery & Development Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Drug Discovery & Development Solutions Ltd. engages in the provision of financial services. The company is headquartered in Singapore. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Katholieke Universiteit Leuven | College/University | Doctorate Degree | |
| GALAPAGOS NV | Biotechnology | Chief Tech/Sci/R&D Officer | |
| HC Conseil SARL | Corporate Officer/Principal | ||
Callisto SAS
 Callisto SAS Investment ManagersFinance Callisto SAS provides financial advisory services to management teams for leveraged buy-outs. The private company is based in Paris, France. Hervé Couffin has been the CEO of the French company since 2005. | Investment Managers | Chief Executive Officer | |
| UZA Foundation | Director/Board Member | ||
Deluxe Business Operations, Inc.
 Deluxe Business Operations, Inc. Commercial Printing/FormsCommercial Services Deluxe Business Operations, Inc. used to design and produce printed products. The company products are business forms, checks, envelopes, labels and greeting cards, retail merchandising aids, packaging, shipping and warehouse supplies. The company was founded in 1952 and was headquartered in Groton, MA. | Commercial Printing/Forms | Director of Finance/CFO | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Ipsen Biopharmaceuticals, Inc. | Chief Tech/Sci/R&D Officer | ||
Partners In Care Maryland, Inc.
 Partners In Care Maryland, Inc. Miscellaneous Commercial ServicesCommercial Services Partners In Care Maryland, Inc. engages in private non-profit organization offering programs and services that support the independence of older adults in communities. The company was founded in 1993 and is headquartered in Pasadena, MD. | Miscellaneous Commercial Services | Chairman | |
| OPGEN, INC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Bank of Clarke
 Bank of Clarke Regional BanksFinance Bank of Clarke provides various banking services. It offers loans, debit and credit card, foreign currency transactions and individual retirement accounts facility to its customer. The firm also focuses on niche markets, which include local residential construction, health facilities and municipal government offices. The company was founded in 1881 and is headquartered in Berryville, VA. | Regional Banks | Comptroller/Controller/Auditor | |
| Shenandoah University | College/University | Undergraduate Degree | |
| PEPGEN INC. | Biotechnology | Director/Board Member | |
| INVIVYD, INC. | Biotechnology | Director/Board Member | |
| University of Pennsylvania | College/University | Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 35 |
| Belgien | 7 |
| Frankreich | 5 |
| Schweiz | 3 |
| Israel | 2 |
Sektoral
| Health Technology | 28 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Finance | 3 |
| Government | 2 |
Operativ
| Director/Board Member | 174 |
| Corporate Officer/Principal | 107 |
| Independent Dir/Board Member | 54 |
| Undergraduate Degree | 37 |
| Chief Executive Officer | 33 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| Alexandre LeBeaut | 22 |
| David Meek | 19 |
| Christophe Jean | 19 |
| Hélène Auriol-Potier | 18 |
| Ivana Magovcevic-Liebisch | 18 |
| Pierre Martinet | 17 |
| Mark Goldberg | 17 |
| Howard Mayer | 16 |
| Scott Jackson | 15 |
| Timothy Pearson | 15 |
| Rachel King | 14 |
| Sotirios G. Stergiopoulos | 13 |
| Scott Koenig | 13 |
| Lisa V. DeLuca | 13 |
- Börse
- Insiders
- Harout Semerjian
- Unternehmensverbindungen
